cAMP 通路与肾上腺皮质发育和生长的调控。
The cAMP pathway and the control of adrenocortical development and growth.
机构信息
CNRS UMR6247, INSERM U931, Génétique Reproduction et Développement, Clermont Université, Aubière, France.
出版信息
Mol Cell Endocrinol. 2012 Mar 31;351(1):28-36. doi: 10.1016/j.mce.2011.10.006. Epub 2011 Oct 15.
Abstract
In the last 10 years, extensive studies showed that the cAMP pathway is deregulated in patients suffering from adrenocortical tumours, and particularly in primary pigmented nodular adrenocortical disease (PPNAD). Here we describe how evidence arising from the analysis of patients' data, mouse models and in vitro experiments, have shed light on the cAMP pathway as a central player in adrenal physiopathology. We also show how novel data generated from mouse models may point to new targets for potential therapies.
摘要
在过去的 10 年中，大量研究表明，cAMP 通路在患有肾上腺皮质肿瘤的患者中失调，特别是在原发性色素性结节性肾上腺皮质疾病（PPNAD）中。在这里，我们描述了从患者数据分析、小鼠模型和体外实验中获得的证据如何揭示 cAMP 通路作为肾上腺病理生理学的核心参与者。我们还展示了从小鼠模型中获得的新数据如何可能指向潜在治疗的新靶点。
相似文献
1
The cAMP pathway and the control of adrenocortical development and growth.cAMP 通路与肾上腺皮质发育和生长的调控。
Mol Cell Endocrinol. 2012 Mar 31;351(1):28-36. doi: 10.1016/j.mce.2011.10.006. Epub 2011 Oct 15.
2
How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?cAMP/蛋白激酶 A 信号通路如何导致肾上腺皮质和其他组织的肿瘤？
Mol Cell Endocrinol. 2011 Apr 10;336(1-2):162-8. doi: 10.1016/j.mce.2010.11.018. Epub 2010 Nov 25.
3
cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumors.肾上腺皮质肿瘤中从细胞表面到细胞核的环磷酸腺苷（cAMP）信号通路改变
Endocr Res. 2002 Nov;28(4):765-75. doi: 10.1081/erc-120017071.
4
New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.与肾上腺增生及相关肾上腺皮质肿瘤相关的新基因和/或分子途径。
Mol Cell Endocrinol. 2009 Mar 5;300(1-2):152-7. doi: 10.1016/j.mce.2008.11.010. Epub 2008 Nov 21.
5
Cortisol-secreting adrenocortical tumours in dogs and their relevance for human medicine.犬类分泌皮质醇的肾上腺皮质肿瘤及其与人类医学的相关性。
Mol Cell Endocrinol. 2016 Feb 5;421:34-9. doi: 10.1016/j.mce.2015.06.026. Epub 2015 Jun 27.
6
Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.环 AMP 信号的激活导致由胚系 PRKAR1A 缺陷引起的肾上腺皮质病变与由体细胞 GNAS 突变引起的病变中的不同途径改变。
J Clin Endocrinol Metab. 2012 Apr;97(4):E687-93. doi: 10.1210/jc.2011-3000. Epub 2012 Jan 18.
7
Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease.大结节性肾上腺疾病中依赖环磷酸腺苷的信号转导异常
Ann N Y Acad Sci. 2002 Jun;968:240-55. doi: 10.1111/j.1749-6632.2002.tb04339.x.
8
Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.孕酮和雌二醇受体在正常肾上腺皮质、肾上腺皮质肿瘤及原发性色素沉着性结节性肾上腺皮质疾病中的表达
Endocr Relat Cancer. 2008 Jun;15(2):465-74. doi: 10.1677/ERC-07-0081.
9
Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).原发性色素沉着性结节性肾上腺皮质疾病（PPNAD）中体细胞β-连环蛋白突变的检测
Clin Endocrinol (Oxf). 2008 Sep;69(3):367-73. doi: 10.1111/j.1365-2265.2008.03273.x. Epub 2008 Apr 14.
10
Inhibins and activins: their roles in the adrenal gland and the development of adrenocortical tumors.抑制素和激活素：它们在肾上腺中的作用及其在肾上腺皮质肿瘤发生中的作用。
Mol Cell Endocrinol. 2012 Aug 15;359(1-2):92-100. doi: 10.1016/j.mce.2011.06.005. Epub 2011 Jun 22.
引用本文的文献
1
The Emerging Role of Aldosterone Synthase Inhibitors in Overcoming Renin-Angiotensin-Aldosterone System Therapy Limitations: A Narrative Review.醛固酮合酶抑制剂在克服肾素-血管紧张素-醛固酮系统治疗局限性方面的新作用：一项叙述性综述
Card Fail Rev. 2025 Aug 18;11:e20. doi: 10.15420/cfr.2025.09. eCollection 2025.
2
Overview of endocrine tumor syndromes manifesting as adrenal tumors.表现为肾上腺肿瘤的内分泌肿瘤综合征概述。
Ewha Med J. 2024 Jan;47(1):e4. doi: 10.12771/emj.2024.e4. Epub 2024 Jan 31.
3
Editorial: Cyclic nucleotide phosphodiesterases (PDEs) signaling in the endocrine system.社论：内分泌系统中的环核苷酸磷酸二酯酶（PDEs）信号传导
Front Endocrinol (Lausanne). 2025 Jan 29;16:1548972. doi: 10.3389/fendo.2025.1548972. eCollection 2025.
4
Current insight into the transient X-zone in the adrenal gland cortex.当前对肾上腺皮质瞬态 X 区的认识。
Vitam Horm. 2024;124:297-339. doi: 10.1016/bs.vh.2023.05.003. Epub 2023 Jul 12.
5
Disorders of the adrenal cortex: Genetic and molecular aspects.肾上腺皮质疾病：遗传与分子方面。
Front Endocrinol (Lausanne). 2022 Aug 29;13:931389. doi: 10.3389/fendo.2022.931389. eCollection 2022.
6
Adrenal cortex renewal in health and disease.肾上腺皮质在健康和疾病中的更新。
Nat Rev Endocrinol. 2021 Jul;17(7):421-434. doi: 10.1038/s41574-021-00491-4. Epub 2021 May 19.
7
Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations.醛固酮调节受体和醛固酮驱动性体细胞突变。
Front Endocrinol (Lausanne). 2021 Mar 16;12:644382. doi: 10.3389/fendo.2021.644382. eCollection 2021.
8
Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.儿童患者伴 KCNJ5 变异的库欣综合征经低剂量酮康唑治疗成功。
J Clin Endocrinol Metab. 2021 May 13;106(6):1606-1616. doi: 10.1210/clinem/dgab118.
9
STARD1 Functions in Mitochondrial Cholesterol Metabolism and Nascent HDL Formation. Gene Expression and Molecular mRNA Imaging Show Novel Splicing and a 1:1 Mitochondrial Association.STARD1 在胆固醇代谢和新生 HDL 形成中发挥作用。基因表达和分子 mRNA 成像显示出新型剪接和 1:1 的线粒体关联。
Front Endocrinol (Lausanne). 2020 Oct 20;11:559674. doi: 10.3389/fendo.2020.559674. eCollection 2020.
10
ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.PRKAR1A 突变患者中的 ARMC5 变异可改变皮质醇水平和库欣综合征。
Endocr Relat Cancer. 2020 Sep;27(9):509-517. doi: 10.1530/ERC-20-0273.
本文引用的文献
1
The physiology and biochemistry of adrenarche.肾上腺初现的生理与生化
Endocr Dev. 2011;20:20-27. doi: 10.1159/000321209. Epub 2010 Dec 16.
2
mTOR: from growth signal integration to cancer, diabetes and ageing.mTOR：从生长信号整合到癌症、糖尿病和衰老。
Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35. doi: 10.1038/nrm3025. Epub 2010 Dec 15.
3
β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma.β-连环蛋白的激活与肾上腺皮质癌的特定临床和病理特征以及不良预后相关。
Clin Cancer Res. 2011 Jan 15;17(2):328-36. doi: 10.1158/1078-0432.CCR-10-2006. Epub 2010 Nov 18.
4
Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.Wnt/β-catenin 通路在肾上腺皮质腺瘤中的激活常归因于体细胞 CTNNB1 激活突变，其与较大的无分泌功能的肿瘤相关：一项对分泌和非分泌皮质醇肿瘤的研究。
J Clin Endocrinol Metab. 2011 Feb;96(2):E419-26. doi: 10.1210/jc.2010-1885. Epub 2010 Nov 17.
5
Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.频繁的磷酸二酯酶 11A 基因 (PDE11A) 缺陷与 PRKAR1A 突变引起的 Carney 复合征 (CNC) 相关：PDE11A 可能作为 CNC 表型的修饰因子，导致肾上腺和睾丸肿瘤。
J Clin Endocrinol Metab. 2011 Jan;96(1):E208-14. doi: 10.1210/jc.2010-1704. Epub 2010 Nov 3.
6
Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.肾上腺皮质特异性 Prkar1a 敲除小鼠中库欣综合征和胎儿特征再现。
PLoS Genet. 2010 Jun 10;6(6):e1000980. doi: 10.1371/journal.pgen.1000980.
7
The potential role of mTOR inhibitors in the treatment of endocrine tumors.mTOR 抑制剂在治疗内分泌肿瘤中的潜在作用。
J Endocrinol Invest. 2010 Apr;33(4):276-81. doi: 10.1007/BF03345792. Epub 2010 May 5.
8
Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors.miRNA 对儿童肾上腺皮质肿瘤中胰岛素样生长因子-雷帕霉素靶蛋白信号的调控。
Cancer Res. 2010 Jun 1;70(11):4666-75. doi: 10.1158/0008-5472.CAN-09-3970. Epub 2010 May 18.
9
Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development.β-连环蛋白的组成性激活可诱导肾上腺增生，并促进肾上腺癌的发展。
Hum Mol Genet. 2010 Apr 15;19(8):1561-76. doi: 10.1093/hmg/ddq029. Epub 2010 Jan 27.
10
Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages.Shh 信号调节肾上腺皮质的发育，并鉴定类固醇生成谱系的祖细胞。
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21185-90. doi: 10.1073/pnas.0909471106. Epub 2009 Dec 1.
Zotero 插件